遗传性代谢病在血液系统的异常表现

摘要/Abstract

摘要：

遗传性代谢病种类多，发病率低，临床表现多样且非特异。遗传代谢病主要影响神经系统，也会影响血液系统，表现为血细胞的形态、数目及骨髓异常。目前临床对遗传代谢病的血液系统异常认识不足，易造成误诊。文章主要对伴有血液系统异常的5大类遗传性代谢病（溶酶体病、维生素代谢障碍、有机酸及氨基酸代谢障碍和其他类疾病）的异常血液表现进行综述，有助于疾病的早期诊断。

Abstract: There are a variety of inherited metabolic diseases (IMD), the incidence is low and clinical manifestations are not characteristic. IMD primarily affect not only the nervous system, but also the blood system, which characterized by the abnormalities of blood cells and bone marrow. Because of some clinician's lack of this knowledge, some patients are prone to be misdiagnosed. To promote early diagnosis, this article reviews five groups of IMD (lysosomal storage disease, vitaminopathies, organic aciduria, aminoacidopathies and others) and different hematological abnormal manifestations.

黄丽珍, 伍金林, 屈艺, 综述. 遗传性代谢病在血液系统的异常表现[J]. 临床儿科杂志, 2014, 32(6): 591-594.

HUANG Lizhen,WU Jinlin,QU Yi,
. Hematological abnormality in inherited metabolic diseases　[J]. , 2014, 32(6): 591-594.

参考文献

[1] Evangeliou A，Dafnis E，Perdikoyanni C，et al. Hematological abnormalities in inborn errors of metabolism - how frequent are they? The Cretan experience[J].Pediatr Hematol Oncol，2002，19(8)：581-585.
[2] de Lonlay P，Fenneteau O，Touati G，et al. Haematologic manifestations of inborn errors of metabolism.[J].Arch pediatr，2002，9(8)：822-835.
[3] Weisberger J，Emmons F，Gorczyca W. Cytochemical diagnosis of Gaucher's disease by iron stain[J]. Br J Haematol，2004，124(6)：696.
[4] Fenneteau O，Lainey E. Bone marrow examination of inherited diseases in children[J]. Ann Biol Clin (Paris)，2007，65(5)：483-503.
[5] Stirnemann J，Vigan M，Hamroun D，et al. The French Gaucher's disease registry：clinical characteristics，complications and treatment of 562 patients[J]. Orphanet J Rare Dis，2012，7：77.
[6] Lecourt S，Mouly E，Freida D，et al. A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 gaucher disease patients[J].PLo S One，2013，8(7)：e692937.
[7] Hughes D，Cappellini MD，Berger M，et al. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease[J]. Br J Haematol，2007，138(6)：676-686.
[8] Thomas AS，Mehta A，Hugehes DA. Gaucher disease：haematological presentations and complications[J]. Br J Haematol， 2014，165(4)：427-440：
[9] de Fost M，Vom Dahl S，Weverling GJ，et al. Increased incidence of cancer in adult Gaucher disease in Western Europe[J]. Blood Cells Mol Dis，2006，36(1)：53-58.
[10] Arends M，van Dussen L，Biegstraaten M，et al. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature[J]. Br J Haematol，2013，161(6)：832-842.
[11] Kuemmel TA，Thiele J，Schroeder R，et al. Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line，mimicking human Niemann-Pick disease type A - A light and electron microscopic study[J]. Pathol Res Prac，1997，193(10)：663-671.
[12] Louwette S，Regal L，Wittevrongel C，et al. NPC1 defect results in abnormal platelet formation and function：studies in Niemann-Pick disease type C1 patients and zebrafish[J]. Hum Mol Genet，2013，22(1)：61-73.
[13] Karaman S，Urganci N，Kutluk G，et al. Niemann-Pick disease associated with hemophagocytic syndrome[J]. Turk J Haematol，2010，27(4)：303-307.
[14] Watkins D，Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism[J]. Am J Med Genet C Semin Med Genet，2011，157C(1)：33-44.
[15] Sharma AP，Greenberg CR，Prasad AN，et al. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder[J]. Pediatr Nephrol，2007，22(12)：2097-2103.
[16] Wu S，Gonzalez-Gomez I，Coates T，et al. Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis[J]. Pediatr Haematol Oncol，2005，22(8)：717-721.
[17] Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children[J]. Br J Haematol，2006，134(2)：125-136.
[18] Vaidyanathan K，Narayanan MP，Vasudevan DM. Organic acidurias：an updated review[J]. Indian J Clin Biochem，2011，26(4)：319-325.
[19] Yang Y，Yao Z，Song J，et al. Outcome of organic acidurias in China[J]. Ann Acad Med Singapore，2008，37(12 Suppl)：120-123.
[20] Narayanan MP，Kannan V，Vinayan KP，et al. Diagnosis of major organic acidurias in children：two years experience at a tertiary care centre[J].Indian J Clin Biochem，2011，26(4)：347-353.
[21] 刘玉鹏，马艳艳，吴桐菲，等.早发型甲基丙二酸尿症160例新生儿期异常表现[J].中华儿科杂志，2012，50(6)：410-414．
[22] Inoue S，Krieger I，Sarnaik A，et al. Inhibition of bone marrow stem cell growth in vitro by methylmalonic acid：a mechanism for pancytopenia in a patient with methylmalonic acidemia[J]. Pediatr Res，1981，15(2)：95-98.
[23] Kelleher JF Jr，Yudkoff M，Hutchinson R，et al. The pancytopenia of isovaleric acidemia.[J]. Pediatr，1980，65(5)：1023-1027.
[24] Malbora B，Avci Z，Hasanoglu A，et al. Late onset of isovaleric acidemia presenting with bicytopenia[J]. Turk J Haematol，2010，27(3)：216-218.
[25] Cattaneo M. Hyperhomocysteinemia and thrombosis[J]. Lipid，2001，36Suppl：S13-S26.
[26] Palacin M，Borsani G，Sebastio G. The molecular bases of cystinuria and lysinuric protein intolerance[J]. Curr Opin Genet Dev，2001，11(3) ：328-335.
[27] Parenti G，Sebastio G，Strisciuglio P，et al. Lysinuric protein intolerance characterized by bonemarrow abnormalities and severe clinical course[J]. J Pediatr，1995，126(2)：246-251.
[28] Barilli A，Rotoli BM，Visigalli R，et al. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance[J]. Mol Genet Metab，2012，105(4)：585-589.
[29] Ogier de Baulny H，Schiff M，Dionisi-Vici C. Lysinuric protein intolerance (LPI)：a multi organ disease by far more complex than a classic urea cycle disorder[J].Mol Genet Metab，2012，106(1)：12-17.
[30] Visser G，Rake JP，Fernandes J，et al. Neutropenia，neutrophil dysfunction，and inflammatory bowel disease in glycogen storage disease type Ib：results of the european study on glycogen storage disease type I[J]. J Pediatr，2000，137(2)：187-191.
[31] Tumino M，Meli C，Farruggia P，et al. Clinical manifestations and management of four children with Pearson syndrome[J]. Am J Med Genet A，2011，155A(12)：3063-3066.
[32] Morel A，Joris N，Meuli R，et al. Early neurological impairment and severe anemia in a newborn with Pearson syndrome[J]. Eur J Pediatr，2009，168(3)：311-315.
[33] Giese A，Kirschner-Schwabe R，Blumchen K，et al. Prenatal manifestation of pancytopenia in Pearson marrow-pancreas syndrome caused by a mitochondrial DNA deletion[J]. Am J Med Genet A，2007，143A(3)：285-288.
[34] Manea EM，Leverger G，Bellmann F，et al. Pearson syndrome in the neonatal period：two case reports and review of the literature[J]. J Pediatr Hematol Oncol，2009，31(12)：947-951.
[35] El Raziky MS，Ali A，El Shahawy A，et al. Acute hemolytic anemia as an initial presentation of Wilson disease in children[J].J Pediatr Hematol Oncol，2014 36(3) ：173-178.
[36] Balkema S，Hamaker ME，Visser HP ，et al. Haemolytic anaemia as a first sign of Wilson's disease[J]. Neth J Med，2008，66(8)：344-347.
[37] Tavil B，Sivri HSK，Coskun T，et al. Haematological findings in children with inborn errors of metabolism[J]. J Inherit Metab Dis，2006，29(5)：607-611.